drugset / Trial / NCT00789360
Staccato Loxapine Pulmonary Safety in Healthy Volunteers
RandomizedCrossoverQuadruple-blindTreatment
Summary
The objective of this trial is to assess the pulmonary safety of 2 inhaled doses of Staccato Loxapine within a day.
Timeline
- Start
- 2008-11
- Primary completion
- 2009-04
- Completion
- 2009-04
Outcome
Missed primary endpoint
registry Maximum LS mean change difference 0.0917 (90% CI -0.028 to 0.212) NCT00789360 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | loxapine | Small molecule | 10 mg | Inhaled |
Indications
No indication recorded.